한글목차

세계의 특수효소 시장 규모는 2024년에 62억 2,000만 달러로 평가되었고 2030년에는 89억 1,000만 달러에 달할 것으로 예측되며, 예측기간 중 CAGR은 6.31%를 나타낼 전망입니다.

전 세계 특수 효소 시장은 의약품, 진단, 식품 가공 및 생명 공학 부문의 수요 증가에 힘입어 강력한 성장을 보이고 있습니다. 프로테아제, 카보히드라제, 리파아제, 폴리머라제 등 이러한 효소는 특정 반응 및 용도에 맞게 설계되어 높은 효율성과 선택성을 제공합니다. 산업용 효소와 달리 특수 효소는 사용량이 적지만, 특히 의료 진단, 치료 및 연구 분야에서 높은 부가가치를 창출합니다. 제약 산업에서는 특수 효소가 의약품 제형, 생체 촉매 및 치료제, 특히 효소 결핍 장애 및 대사 질환 치료에 점점 더 많이 사용되고 있습니다. 만성 질환의 증가, 인구 고령화, 맞춤형 의약품에 대한 관심은 이러한 수요를 더욱 부추기고 있습니다. 분자 진단 분야에서 폴리머라제 및 뉴클레아제와 같은 효소는 DNA 증폭 및 분석에 중요한 역할을 하여 질병의 정확성과 진단 속도를 향상시킵니다.

시장 성장 촉진요인

고급 의료 솔루션에 대한 수요 증가

주요 시장 과제

높은 제조 비용

주요 시장 동향

지속가능성 및 생체촉매 작용

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 특수 효소 시장 전망

• 시장 규모와 예측
  • 금액 및 수량별
• 시장 점유율 및 예측
  • 유형별(프로테아제, 폴리머라제, 뉴클레아제, 카보히드라제, 리파아제 등)
  • 발생원별(미생물, 식물, 동물)
  • 용도별(생명공학, 의약품, 진단, 연구개발)
  • 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
  • 기업별(2024년)
• 시장 맵
  • 유형별
  • 발생원별
  • 용도별
  • 지역별
• 가격 분석

제5장 유럽의 특수효소 시장 전망

• 시장 규모와 예측
  • 금액 및 수량별
• 시장 점유율 및 예측
  • 유형별(프로테아제, 폴리머라제, 뉴클레아제, 카보히드라제, 리파아제 등)
  • 발생원별(미생물, 식물, 동물)
  • 용도별(생명공학, 의약품, 진단, 연구개발)
  • 지역별
• 가격 분석
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제6장 아시아태평양의 특수 효소 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 가격 분석
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제7장 북미의 특수 효소 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 가격 분석
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제8장 중동 및 아프리카의 특수 효소 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 가격 분석
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 남아프리카
  • 아랍에미리트(UAE)

제9장 남미의 특수 효소 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 가격 분석
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제10장 시장 역학

• 성장 촉진요인
  • 소화기 질환의 이환율 증가
  • 의약품 제조에 있어서의 높은 사용률
  • 다국적 효소 제조업체에 의한 생명공학과 유전학에 대한 지속적인 투자
• 과제
  • 고비용과 유지보수 문제
  • 규제상의 과제

제11장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제12장 세계의 특수 효소 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• F. Hoffmann-La Roche AG
• Codexis Inc.
• BASF SE
• Koninklijke DSM NV
• DuPont Nutrition Biosciences
• Advanced Enzyme Technologies Limited
• Novozymes A/S
• Amano enzyme Inc.
• BBI Solutions OEM Limited
• Sekisui Diagnostics

제15장 전략적 제안

제16장 기업 소개와 면책사항

영문목차

Global Specialty Enzymes Market was valued at USD 6.22 billion in 2024 and is expected to reach USD 8.91 billion by 2030 with a CAGR of 6.31% during the forecast period. The global specialty enzymes market is experiencing strong growth, driven by rising demand across pharmaceuticals, diagnostics, food processing, and biotechnology sectors. These enzymes, which include proteases, carbohydrases, lipases, and polymerases, are designed for specific reactions and applications, offering high efficiency and selectivity. Unlike industrial enzymes, specialty enzymes are used in smaller volumes but add high value, particularly in medical diagnostics, therapeutics, and research. In the pharmaceutical industry, specialty enzymes are increasingly used in drug formulation, biocatalysis, and as therapeutic agents, especially for treating enzyme deficiency disorders and metabolic conditions. The rise in chronic diseases, aging populations, and interest in personalized medicine are further fueling demand. In molecular diagnostics, enzymes such as polymerases and nucleases play a crucial role in DNA amplification and analysis, enhancing the accuracy and speed of disease detection.

Key Market Drivers

Growing demand for advanced healthcare solutions

The growing demand for advanced healthcare solutions is significantly impacting the specialty enzymes market. As healthcare systems around the world shift towards precision medicine, targeted therapies, and early diagnostics, specialty enzymes have emerged as essential components in these innovations. These enzymes are tailored for specific biological reactions, making them ideal for complex medical applications such as drug formulation, gene therapy, and diagnostic testing. In drug development, specialty enzymes are used to synthesize active pharmaceutical ingredients with high specificity and fewer side effects. They also support biocatalysis processes that enhance the efficiency and environmental sustainability of pharmaceutical manufacturing. Enzyme replacement therapies, which treat rare genetic and metabolic disorders, are gaining traction as awareness and diagnosis improve. This has created a surge in demand for enzymes that can be used directly as therapeutic agents. In diagnostics, specialty enzymes enable accurate and rapid detection of diseases through applications such as polymerase chain reactions (PCR), ELISA tests, and next-generation sequencing. These tools have become increasingly important in identifying conditions ranging from infectious diseases to cancer and genetic disorders.

With aging populations and a rise in lifestyle-related illnesses, there is increased pressure on healthcare systems to adopt technologies that are both effective and scalable. Specialty enzymes support this need by improving treatment outcomes and enabling high-throughput diagnostic platforms. Biotechnology and pharmaceutical companies are investing in enzyme engineering to develop more stable and efficient products. As healthcare moves toward more personalized, data-driven models, the role of specialty enzymes in diagnostics and therapeutics will continue to expand significantly.

Key Market Challenges

High production cost

High production cost is a significant barrier in the specialty enzymes market. These enzymes are typically produced through advanced biotechnological methods such as microbial fermentation, recombinant DNA technology, and protein engineering. Each stage of development-from strain selection and genetic modification to purification and formulation-requires specialized equipment, skilled labor, and stringent quality control, all of which contribute to elevated manufacturing costs. The complexity of maintaining enzyme activity and stability throughout the production process further adds to expenses. Specialty enzymes often need to retain functionality under specific pH, temperature, or moisture conditions, which calls for customized formulations and storage solutions. These requirements make large-scale production more expensive compared to standard industrial enzymes. For pharmaceutical and diagnostic applications, the cost increases due to the need for clinical validation, regulatory compliance, and purity standards. High-purity enzymes must be free from contaminants and consistent in performance, leading to costly purification and testing procedures. This financial burden can limit the adoption of specialty enzymes, especially in emerging markets or in price-sensitive sectors such as food processing. The high cost of production also impacts pricing strategies, reducing profit margins and making it harder for smaller companies to compete. Reducing production costs through innovation and process optimization is key to expanding market access.

Key Market Trends

Sustainability & Biocatalysis

Sustainability and biocatalysis are becoming central drivers in the specialty enzymes market, as industries seek cleaner, greener alternatives to traditional chemical processes. Enzymes act as biocatalysts, enabling environmentally friendly reactions with high specificity and lower energy requirements. This aligns with global efforts to reduce carbon footprints and minimize hazardous waste across sectors like pharmaceuticals, textiles, food processing, and biofuels. In chemical manufacturing, enzymes replace harsh solvents and high-temperature reactions, supporting eco-friendly production while improving process efficiency. This shift is particularly important in regulated industries under increasing pressure to meet sustainability benchmarks and environmental standards. Biocatalysis also offers benefits such as reduced water consumption and fewer byproducts, which help companies optimize resource usage and reduce costs. In biofuel production, enzymes play a vital role in breaking down biomass into fermentable sugars, supporting the transition to renewable energy sources. Governments and private investors are backing such enzyme-based innovations to achieve climate targets and foster circular economy practices. Consumer demand for sustainable products is also influencing manufacturers to integrate biocatalysts into their workflows.The push for green chemistry is expected to accelerate investment in enzyme discovery, engineering, and industrial-scale application. Biocatalysis is not just a technological advancement-it is a strategic necessity for companies aiming to lead in a sustainable future.

Key Market Players

• F. Hoffmann-La Roche AG
• Codexis Inc.
• BASF SE
• Koninklijke DSM N.V.
• DuPont Nutrition Biosciences
• Advanced Enzyme Technologies Limited
• Novozymes A/S
• Amano enzyme Inc.
• BBI Solutions OEM Limited
• Sekisui Diagnostics

Report Scope:

In this report, the Global Specialty Enzymes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Specialty Enzymes Market, By Type:

• Proteases
• Polymerases & Nucleases
• Carbohydrases
• Lipases
• Others

Specialty Enzymes Market, By Source:

• Microorganisms
• Plants
• Animals

Specialty Enzymes Market, By Application:

• Biotechnology
• Pharmaceuticals
• Diagnostics
• Research & Development

Specialty Enzymes Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Specialty Enzymes Market.

Available Customizations:

Global Specialty Enzymes Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Specialty Enzymes Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value & Volume
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 4.2.2. By Source (Microorganisms, Plants, Animals)
  • 4.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 4.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Source
  • 4.3.3. By Application
  • 4.3.4. By Region
• 4.4. Pricing Analysis

5. Europe Specialty Enzymes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 5.2.2. By Source (Microorganisms, Plants, Animals)
  • 5.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 5.2.4. By Region
• 5.3. Pricing Analysis
• 5.4. Europe: Country Analysis
  • 5.4.1. France Specialty Enzymes Market Outlook
    • 5.4.1.1. Market Size & Forecast
      • 5.4.1.1.1. By Value & Volume
    • 5.4.1.2. Market Share & Forecast
      • 5.4.1.2.1. By Type
      • 5.4.1.2.2. By Source
      • 5.4.1.2.3. By Application
  • 5.4.2. Germany Specialty Enzymes Market Outlook
    • 5.4.2.1. Market Size & Forecast
      • 5.4.2.1.1. By Value & Volume
    • 5.4.2.2. Market Share & Forecast
      • 5.4.2.2.1. By Type
      • 5.4.2.2.2. By Source
      • 5.4.2.2.3. By Application
  • 5.4.3.United Kingdom Specialty Enzymes Market Outlook
    • 5.4.3.1. Market Size & Forecast
      • 5.4.3.1.1. By Value & Volume
    • 5.4.3.2. Market Share & Forecast
      • 5.4.3.2.1. By Type
      • 5.4.3.2.2. By Source
      • 5.4.3.2.3. By Application
  • 5.4.4. Italy Specialty Enzymes Market Outlook
    • 5.4.4.1. Market Size & Forecast
      • 5.4.4.1.1. By Value & Volume
    • 5.4.4.2. Market Share & Forecast
      • 5.4.4.2.1. By Type
      • 5.4.4.2.2. By Source
      • 5.4.4.2.3. By Application
  • 5.4.5. Spain Specialty Enzymes Market Outlook
    • 5.4.5.1. Market Size & Forecast
      • 5.4.5.1.1. By Value & Volume
    • 5.4.5.2. Market Share & Forecast
      • 5.4.5.2.1. By Type
      • 5.4.5.2.2. By Source
      • 5.4.5.2.3. By Application

6. Asia-Pacific Specialty Enzymes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 6.2.2. By Source (Microorganisms, Plants, Animals)
  • 6.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 6.2.4. By Region
• 6.3. Pricing Analysis
• 6.4. Asia-Pacific: Country Analysis
  • 6.4.1. China Specialty Enzymes Market Outlook
    • 6.4.1.1. Market Size & Forecast
      • 6.4.1.1.1. By Value & Volume
    • 6.4.1.2. Market Share & Forecast
      • 6.4.1.2.1. By Type
      • 6.4.1.2.2. By Source
      • 6.4.1.2.3. By Application
  • 6.4.2. India Specialty Enzymes Market Outlook
    • 6.4.2.1. Market Size & Forecast
      • 6.4.2.1.1. By Value & Volume
    • 6.4.2.2. Market Share & Forecast
      • 6.4.2.2.1. By Type
      • 6.4.2.2.2. By Source
      • 6.4.2.2.3. By Application
  • 6.4.3. Japan Specialty Enzymes Market Outlook
    • 6.4.3.1. Market Size & Forecast
      • 6.4.3.1.1. By Value & Volume
    • 6.4.3.2. Market Share & Forecast
      • 6.4.3.2.1. By Type
      • 6.4.3.2.2. By Source
      • 6.4.3.2.3. By Application
  • 6.4.4. South Korea Specialty Enzymes Market Outlook
    • 6.4.4.1. Market Size & Forecast
      • 6.4.4.1.1. By Value & Volume
    • 6.4.4.2. Market Share & Forecast
      • 6.4.4.2.1. By Type
      • 6.4.4.2.2. By Source
      • 6.4.4.2.3. By Application
  • 6.4.5. Australia Specialty Enzymes Market Outlook
    • 6.4.5.1. Market Size & Forecast
      • 6.4.5.1.1. By Value & Volume
    • 6.4.5.2. Market Share & Forecast
      • 6.4.5.2.1. By Type
      • 6.4.5.2.2. By Source
      • 6.4.5.2.3. By Application
      • 6.4.5.2.4. By Application

7. North America Specialty Enzymes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 7.2.2. By Source (Microorganisms, Plants, Animals)
  • 7.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 7.2.4. By Region
• 7.3. Pricing Analysis
• 7.4. North America: Country Analysis
  • 7.4.1. United States Specialty Enzymes Market Outlook
    • 7.4.1.1. Market Size & Forecast
      • 7.4.1.1.1. By Value & Volume
    • 7.4.1.2. Market Share & Forecast
      • 7.4.1.2.1. By Type
      • 7.4.1.2.2. By Source
      • 7.4.1.2.3. By Application
  • 7.4.2. Canada Specialty Enzymes Market Outlook
    • 7.4.2.1. Market Size & Forecast
      • 7.4.2.1.1. By Value & Volume
    • 7.4.2.2. Market Share & Forecast
      • 7.4.2.2.1. By Type
      • 7.4.2.2.2. By Source
      • 7.4.2.2.3. By Application
  • 7.4.3. Mexico Specialty Enzymes Market Outlook
    • 7.4.3.1. Market Size & Forecast
      • 7.4.3.1.1. By Value & Volume
    • 7.4.3.2. Market Share & Forecast
      • 7.4.3.2.1. By Type
      • 7.4.3.2.2. By Source
      • 7.4.3.2.3. By Application

8. Middle East and Africa Specialty Enzymes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 8.2.2. By Source (Microorganisms, Plants, Animals)
  • 8.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 8.2.4. By Region
• 8.3. Pricing Analysis
• 8.4. MEA: Country Analysis
  • 8.4.1. Saudi Arabia Specialty Enzymes Market Outlook
    • 8.4.1.1. Market Size & Forecast
      • 8.4.1.1.1. By Value & Volume
    • 8.4.1.2. Market Share & Forecast
      • 8.4.1.2.1. By Type
      • 8.4.1.2.2. By Source
      • 8.4.1.2.3. By Application
  • 8.4.2. South Africa Specialty Enzymes Market Outlook
    • 8.4.2.1. Market Size & Forecast
      • 8.4.2.1.1. By Value & Volume
    • 8.4.2.2. Market Share & Forecast
      • 8.4.2.2.1. By Type
      • 8.4.2.2.2. By Source
      • 8.4.2.2.3. By Application
  • 8.4.3. UAE Specialty Enzymes Market Outlook
    • 8.4.3.1. Market Size & Forecast
      • 8.4.3.1.1. By Value & Volume
    • 8.4.3.2. Market Share & Forecast
      • 8.4.3.2.1. By Type
      • 8.4.3.2.2. By Source
      • 8.4.3.2.3. By Application

9. South America Specialty Enzymes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Proteases, Polymerases & Nucleases, Carbohydrase's, Lipases, And Others)
  • 9.2.2. By Source (Microorganisms, Plants, Animals)
  • 9.2.3. By Application (Biotechnology, Pharmaceuticals, Diagnostics, And Research & Development)
  • 9.2.4. By Region
• 9.3. Pricing Analysis
• 9.4. South America: Country Analysis
  • 9.4.1. Brazil Specialty Enzymes Market Outlook
    • 9.4.1.1. Market Size & Forecast
      • 9.4.1.1.1. By Value & Volume
    • 9.4.1.2. Market Share & Forecast
      • 9.4.1.2.1. By Type
      • 9.4.1.2.2. By Source
      • 9.4.1.2.3. By Application
  • 9.4.2. Colombia Specialty Enzymes Market Outlook
    • 9.4.2.1. Market Size & Forecast
      • 9.4.2.1.1. By Value & Volume
    • 9.4.2.2. Market Share & Forecast
      • 9.4.2.2.1. By Type
      • 9.4.2.2.2. By Source
      • 9.4.2.2.3. By Application
  • 9.4.3. Argentina Specialty Enzymes Market Outlook
    • 9.4.3.1. Market Size & Forecast
      • 9.4.3.1.1. By Value & Volume
    • 9.4.3.2. Market Share & Forecast
      • 9.4.3.2.1. By Type
      • 9.4.3.2.2. By Source
      • 9.4.3.2.3. By Application

10. Market Dynamics

• 10.1. Drivers
  • 10.1.1. Increasing Prevalence of Digestive Disorders
  • 10.1.2. High Usage in Drugs Manufacturing
  • 10.1.3. Continued Investment in Biotechnology and Genetics by Various Multinational Enzyme Manufacturers
• 10.2. Challenges
  • 10.2.1. High cost and Maintenance Issues
  • 10.2.2. Regulatory challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Mergers & Acquisitions
• 11.3. Product Launches

12. Global Specialty Enzymes Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. F. Hoffmann-La Roche AG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Codexis Inc.
• 14.3. BASF SE
• 14.4. Koninklijke DSM N.V.
• 14.5. DuPont Nutrition Biosciences
• 14.6. Advanced Enzyme Technologies Limited
• 14.7. Novozymes A/S
• 14.8. Amano enzyme Inc.
• 14.9. BBI Solutions OEM Limited
• 14.10. Sekisui Diagnostics

15. Strategic Recommendations

16. About Us & Disclaimer